CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

OKYOOKYO Pharma Ltd

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $1.29 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
CountryUSA
RECENT INSIDER TRADES
  • 2026-06-10 · CERRONE GABRIELE M (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders19
Shares held6,493,711
Value$9.74M
Percent of shares outstanding12.37%
As of quarter end2026-06-30
RECENT NEWS
  • OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
  • OKYO Pharma presents at upcoming ophthalmic scientific conferences
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
OKYO Pharma Ltd (OKYO) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit